Pharmaceutical

Novo Holdings completes Catalent acquisition for $16.5bn

Novo Holdings has completed the previously announced acquisition of Catalent in an all-cash transaction valued at around $16.5bn.

Dec 19, 2024 - 06:00
Novo Holdings completes Catalent acquisition for $16.5bn
Novo Holdings has completed the previously announced acquisition of Catalent in an all-cash transaction valued at around $16.5bn.
Read the original article

Tags:

Previous Article

Corcept’s ALS Modulator Fails to Meet Primary Endpoint in Phase 2 Study

Next Article

Pharma’s data and analytics market forecast to reach to $2.1bn by 2028

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

From data to action: Igniting the healthcare revolution

From data to action: Igniting the healthcare revolution

Jun 30, 2024

Cipla sees highest patent filings and grants during Sep...

Dec 10, 2023

STAT+: After missing vaccine glory in pandemic, GSK looks to dominate other diseases

STAT+: After missing vaccine glory in pandemic, GSK loo...

Jun 8, 2023